
Hi {{ first name | there}},
Last week's poll gave a useful signal. The biggest group – 30% of the readers – chose "I need body-based tools more than mindset tips." Another 23% wanted "the faster, more aggressive version." Then came two middle buckets with 19% stating that they know what to do but do not do it in the moment and 15% that they already use something like this. The smallest group – 13% – said they notice the stress spike, but too late.
That matters. It suggests most readers are not mainly asking for more abstract mindset advice. They want something more physical, more measurable, and more decision-relevant – either a body-level tool they can actually use, or a sharper protocol with a higher ceiling.
So this week, we wanted to move in that direction.
Not "how do I calm down a little faster?"
But "is one of the most popular longevity drugs quietly flattening the return you get from training?"
That is the kind of question worth opening.
It is practical.
It is measurable.
And it matters to readers who are trying to get fitter, metabolically sharper, and harder to break – without accidentally building a stack that works against itself.
Evidence-first health, delivered – and built.
And if you know someone taking metformin while trying to get fitter, stronger, or metabolically healthier, forward this issue to them. Subscribe here.
-LONGEVITY PLAYBOOK-
When Good Inputs Collide

Metformin is one of the most widely used drugs in metabolic medicine.
Exercise is still one of the most reliable ways to improve insulin sensitivity, aerobic fitness, and long-term cardiometabolic resilience.
So the obvious assumption is that combining them should be a win.
That assumption now looks too simple.
A new randomized trial followed adults at risk for metabolic syndrome through 16 weeks of structured training at either low or high intensity, with either placebo or metformin. The key result: only the high-intensity plus placebo group improved clamp-measured metabolic insulin sensitivity. The high-intensity plus metformin group did not.
That was not an isolated signal.
In a companion randomized trial, the placebo groups improved VO2max, while the metformin groups did not. Metformin also blunted vascular insulin-sensitivity gains.
That does not mean metformin is "bad."
It means the stack is more complicated than many people assume.
A drug can lower glucose and still interfere with part of the adaptation signal that exercise normally creates. That is the real story here – not medication panic, and not anti-metformin posturing. Just a more serious look at what happens when two "good" health inputs do not combine as cleanly as expected.
Mechanistically, the picture is still being worked out. But the broad idea is straightforward: exercise improves metabolic health partly through repeated stress, repair, and remodeling. Metformin may damp part of that remodeling in some settings – especially around mitochondrial, vascular, and insulin-sensitivity responses.
This concern is not brand new. What is different now is that the newer randomized trials make the tradeoff much harder to dismiss.
Why does this matter now?
Because more readers are trying to build smarter health stacks.
And this is exactly where things get interesting: not when a drug works in isolation, and not when exercise works in isolation, but when the combination turns out to be less additive than the wellness logic suggests.
Reality check
These studies were done in adults at risk for metabolic syndrome under controlled training conditions. They do not prove that every person on metformin will lose fitness gains. They do not prove that every population responds the same way. And they definitely do not prove that stopping prescribed metformin is a smart move.
They also relied on surrogate outcomes – clamp-based insulin sensitivity, vascular measures, and VO2max – not long-term hard outcomes like diabetes progression, cardiovascular events, or mortality.
So the honest conclusion is not:
"Metformin ruins exercise."
It is:
"If you are using metformin and training seriously, you should stop assuming the combination is automatically synergistic."
Who should care most
This applies most directly to:
people taking metformin for insulin resistance, prediabetes, or type 2 diabetes
people using it off-label for "longevity"
people training specifically for metabolic health or aerobic capacity
It applies less cleanly to:
lean, already-fit athletes
people whose medication plan is currently changing
anyone trying to infer too much from a few weeks of noisy wearable data
But for readers who are in that overlap zone, the takeaway is clear:
Do not assume. Measure response.
THE PROTOCOL
The 4-Week Training-Return Experiment

This is not a medication experiment. It is a measurement experiment.
The goal is simple: stop guessing whether your training is working as well as you think it is.
Step 1 – Pick one repeatable benchmark
Choose one cardio session you can repeat once a week under similar conditions:
the same treadmill walk
the same bike effort
the same outdoor route
the same warm-up
Boring is good here. Consistency is the whole point.
Step 2 – Keep the variables stable
Use the same:
device
route or machine
time window
caffeine pattern
basic fueling pattern
Do not change five things and then try to interpret one result.
Step 3 – Track one primary marker and one field marker
Primary marker: estimated VO2max
Field marker: pace at a fixed heart rate on the same route – or average heart rate at the same pace
That gives you one cleaner "fitness trend" and one practical "real-world performance" check.
Step 4 – Add two simple notes
After each benchmark session, log:
Session effort: 1-10
Next-day recovery: 1-10
If pace is flat but recovery is worse, that matters.
If pace is better at the same heart rate, that matters too.
Step 5 – Ask one blunt question after 4 weeks
Is your training response:
better
flat
oddly sluggish
Flat does not prove metformin is the reason.
But it does justify a more serious review of:
sleep
fueling
recovery
training structure
medication goals
Measurement instructions
Use the same method every time.
If your wearable does not estimate VO2max reliably, use the simpler fallback:
compare pace at the same heart rate on the same route.
Trend matters more than one isolated reading.
Safety line
Do not change or stop prescribed metformin based on this newsletter.
Do not run this experiment if you have recently changed dose, are acutely ill, or are dealing with chest pain, fainting, severe shortness of breath, or repeated hypoglycemia symptoms.
If those show up, seek care promptly.
TINY SCOREBOARD
Reply and paste this in:
Baseline estimated VO2max: _____
Week 4 estimated VO2max: _____
Baseline pace at fixed HR: _____
Week 4 pace at fixed HR: _____
Average session effort: _____
Recovery trend: better / flat / worse
Metformin status: prescribed / off-label / not using
-SPONSORED-
Prescribing clarity for healthcare business
If your healthcare job looks more like spreadsheets than scrubs, keep reading.
Healthcare Brew is a free daily newsletter covering regulation, reimbursement, M&A, and the trends shaping payers, providers, and pharma—without the fluff or clinical deep dives.
Just clear context for people making decisions at the intersection of business and healthcare.
Join 135K+ like-minded professionals reading Healthcare Brew for free.
-BIOMARKER OF THE WEEK-
Estimated VO2max
What it is
VO2max is the highest rate at which your body can take in, transport, and use oxygen during hard exercise. In plain English, it is one of the best single summaries of your cardiorespiratory fitness – the combined performance of your heart, lungs, blood vessels, and working muscles under load. Low cardiorespiratory fitness is strongly linked to higher cardiovascular and all-cause mortality risk, which is why this marker matters beyond sport.
What it is actually telling you
Estimated VO2max is not just a "fitness score." It is a rough readout of how well your system handles sustained aerobic work.
When it improves, that usually reflects some combination of:
better oxygen delivery
better stroke volume and cardiac output
better muscle oxygen use
better overall aerobic efficiency
That is why it is useful here. This issue is about training response. And in the recent metformin-exercise trials, VO2max improved in the placebo-plus-exercise groups but not in the metformin-plus-exercise groups.
How it is measured
The gold-standard version is measured in a lab during maximal exercise testing with gas analysis. What most readers will see instead is an estimated VO2max from a wearable, app, treadmill, or submaximal field test. Those estimates can be useful, but they are still estimates. A 2022 meta-analysis found that exercise-based wearable estimates perform better than resting estimates overall, but the individual-level error can still be large. That means the number is best used for trend-tracking, not for pretending your watch is a metabolic cart.
How to measure it well
Use the same device, the same test conditions, and the same type of effort over time.
That means keeping as much as possible stable:
same watch or app
same route or machine
similar weather or indoor setup
similar time of day
similar caffeine and fueling pattern
Consistency matters more than sophistication. A mediocre measurement done the same way every time is more useful than a "fancy" number collected under changing conditions.
What "better" generally means
Better usually means:
a gradual upward drift in estimated VO2max over weeks or months
the same pace at a lower heart rate
a faster pace at the same heart rate
the same session feeling easier
What does not count as meaningful is obsessing over tiny day-to-day changes. This marker moves slowly. It is much more useful for direction than for daily drama.
How not to overread it
This is where most people go wrong.
A flat VO2max estimate does not automatically mean your training is failing. It can also be affected by:
poor sleep
heat
dehydration
illness
device error
inconsistent pacing
abrupt training changes
So the right question is not, "Did my score go up this week?"
It is, "Is the trend moving in the right direction under similar conditions?"
-MYTH OF THE WEEK-
"If a drug and a behavior are each good on their own, combining them must be better."
That sounds logical.
It is also one of the easiest ways to fool yourself in health.
A lot of people now think in stacks: one drug, one supplement, one training plan, one recovery tool – all layered together under the assumption that more "good inputs" should produce more good results.
But biology does not always work that way.
Sometimes two useful things are additive.
Sometimes they are neutral.
And sometimes one blunts part of what the other would have done on its own.
That is the real myth to break this week.
The newer metformin-exercise trials do not support the lazy version of the stack story. In those studies, metformin appeared to blunt part of the insulin-sensitivity, vascular, and aerobic-fitness response that exercise alone improved.
So the smarter rule is not:
"If both are healthy, combine them."
It is:
"If both are in the stack, measure what the stack is actually doing."
That applies far beyond metformin.
It applies to:
supplements layered onto training
recovery tools layered onto poor sleep
glucose tools layered onto bad diet structure
"longevity" routines built from isolated half-truths
Safer replacement behavior
Do not assume your stack is synergistic.
Measure the return.
Then decide what deserves to stay.
THE SUPPLEMENT
L-Citrulline

What it is
L-citrulline is an amino acid that raises circulating arginine more reliably than arginine itself in many settings, which can increase nitric-oxide production. In practical terms, that is why it gets pulled into conversations about blood flow, oxygen delivery, exercise efficiency, and muscular endurance.
Why people use it
Most people do not take L-citrulline for "metabolic health" directly. They take it because the theory is appealing: better nitric-oxide signaling may improve blood flow to working muscle, reduce the oxygen cost of exercise in some settings, and slightly improve how hard or how long a session feels sustainable. That makes it more relevant to this week’s issue than a glucose-centric supplement, because the real question here is not "how do I lower glucose a bit more?" but "how do I support the training side of the equation?"
What the evidence actually says
The honest read is mixed, modest, and context-dependent.
A 2022 systematic review and meta-analysis found no clear overall benefit for aerobic-exercise performance, which matters because this issue is partly about VO2max and endurance adaptation. A 2021 critical review came to a similar conclusion: the mechanism is plausible, but the actual performance literature is inconsistent and heavily dependent on dose, formulation, timing, population, and the kind of exercise being tested.
Where the signal looks somewhat better is in high-intensity or muscular-endurance settings, not in clean, across-the-board endurance enhancement. Reviews and recent trials suggest there may be useful effects in some resistance-training or repeated-effort contexts, but the effect is not big enough or consistent enough to market as a general performance unlock.
What that means
L-citrulline is best framed as a possible small edge, not a foundational move.
It is not the main event. It is not a proven fix for flattened training response. And it is definitely not proven to reverse the metformin-related blunting seen in the newer exercise trials. That connection is still mechanistic and speculative, not decision-grade human evidence.
Safety / contraindications
This is still a real supplement, not flavored water. People with low blood pressure, significant kidney disease, unusual GI sensitivity, or medication situations that already affect nitric-oxide signaling should be cautious and discuss it with a clinician. And because the evidence is performance-oriented rather than disease-treatment-oriented, it should be treated as optional, not essential.
The more important metformin note
If you are on long-term metformin, the more clinically important nutrient question is often vitamin B12, not L-citrulline. Recent reviews continue to describe metformin-associated B12 deficiency as common and clinically meaningful, with growing concern around neuropathy risk and uneven screening practice.
-SPONSORED-
Is your supplement stack actually working?
Most people have no idea what supplements they're taking. Download SuppCo to organize your routine, audit your nutrients, and see your StackScore. Then you'll know if your stack is helping or just expensive.
-IN THE PRESS-
What we're reading
Cannabis still has an evidence problem in mental health
Medical cannabis has built a lot of cultural momentum. The randomized evidence has not kept pace. A large new review published in The Lancet pooled 54 randomized trials and found little convincing benefit for most mental-health and substance-use disorders, including anxiety, PTSD, psychosis, and opioid-use disorder. There were a few narrower signals, but the broader message was much less flattering than the hype. That makes this a clean reminder that "widely used" and "well supported" are not the same thing.
Why it matters: HEALTH HACK readers should be especially skeptical when a therapy gets popular faster than the evidence matures.
Reuters
Cutting sweetness may not fix cravings after all
This one goes straight at a very common nutrition assumption. In a 6-month clinical trial, people assigned to diets with high, low, or moderate sweet-taste exposure ended up with no meaningful differences in sweet preference, weight, or measured diabetes and cardiovascular risk markers. In other words, the problem may be calorie and sugar load, not sweetness itself. That does not mean unlimited sweet foods are harmless. It does mean "train your palate away from sweetness" may be a weaker obesity strategy than many people think.
Why it matters: This is exactly the kind of belief correction HEALTH HACK does well – practical, counterintuitive, and useful without being gimmicky.
ScienceDaily
A gut bacterium linked to muscle strength
Microbiome headlines are usually too eager. This one is more interesting than average. Researchers reported that Roseburia inulinivorans was associated with human muscle strength, and in mice it appeared to improve muscular performance, increase forelimb grip strength, and shift muscle toward more fast-twitch characteristics. That is not a green light to treat probiotics like resistance training in a capsule. But it is a genuinely intriguing gut-muscle-axis signal – especially for healthy aging and sarcopenia research.
Why it matters: If this line of work holds up, the future of muscle preservation may include more than protein and lifting. For now, though, this is still a "watch closely" story, not a "buy now" story.
Medical Xpress
Dick Van Dyke's longevity advice is simple – and not crazy
The celebrity wrapper is softer than we usually like, but the underlying point is still worth noting. The piece links chronic anger and stress to cardiovascular strain, faster telomere shortening, and a lower likelihood of the healthier habits that tend to support long-term health. So the real takeaway is not "Dick Van Dyke's one weird trick." It is the much more familiar idea that how you handle stress and anger may shape both biology and behavior over time.
Why it matters: Not because a celebrity said it – but because chronic anger and stress still tend to be undercounted as aging variables until they show up as downstream damage.
ScienceAlert
Lab-grown hair follicles just took a real step forward
Hair-regrowth coverage is usually full of false dawns. This one looks more substantial than most. Researchers used an overlooked cell component to help grow functional follicles from mouse cells in the lab, and after transplantation into mice, the follicles integrated into surrounding tissue and kept cycling through loss and regrowth for 68 days. That is still a long way from routine human treatment. But it looks more like a serious regenerative-medicine signal than the usual baldness clickbait.
Why it matters: Even if the cosmetic angle gets the clicks, the deeper story is organ-level regeneration and tissue engineering – which is much more interesting.
Popular Mechanics
-SPONSORED-
Get Rid of Grays Naturally – Now 20% Off
Reverse gray hair with a simple-to-use daily spray for men. Particle Anti-Gray Serum reduces grays with each spray, offering natural-looking results without hair dye or harmful substances. Take 20% off now with code BH20 and start seeing the difference.
-PEPTIDE OF THE WEEK-
Humanin

Humanin is the kind of peptide that sounds tailor-made for the current moment: mitochondrial, protective, metabolically interesting, and adjacent to aging biology.
That is the promise.
The evidence gap is that most of the excitement comes from cell work, animal work, and review-level synthesis – not from decision-grade human intervention trials you can act on this year.
What it is
Humanin is a small peptide encoded within mitochondrial DNA. It is usually described as a mitochondria-derived peptide, and one reason it attracts so much attention is that it appears to sit at the intersection of stress resistance, apoptosis control, and metabolic regulation.
The better-known synthetic analog is HNG, which reviews describe as more potent than native Humanin in several preclinical models.
That sounds impressive.
It also tells you something important: this is still very much a lab-optimization story, not a mature human-performance tool.
How it might work
It may reduce apoptosis signaling in stressed cells.
It may improve resistance to oxidative stress.
It may influence insulin signaling and glucose metabolism.
It may exert endothelial and cardiovascular protective effects under stress conditions.
It may interact with autophagy-related pathways.
It may behave more like a stress-response signal than a straightforward "performance enhancer."
The evidence: claims vs reality
Claim: "Humanin improves insulin sensitivity."
Reality: There is real preclinical signal here. Humanin became especially interesting after experimental work linked it to insulin action and metabolic protection. But that is very different from saying Humanin is a validated human treatment for insulin resistance. Robust real-world intervention data are still missing.
Claim: "Humanin protects the heart and blood vessels."
Reality: Reviews do argue for cardioprotective potential through anti-inflammatory, anti-apoptotic, and oxidative-stress pathways. But this is still mainly a translational story, not a clinic-ready one.
Claim: "Humanin is the next mitochondrial longevity peptide."
Reality: This is where hype outruns the data. The biology is interesting. The human decision-grade evidence is still thin. Much of the human literature is about Humanin as a signal or biomarker, not as a validated treatment.
So the honest read is simple:
Humanin is a research-watchlist peptide, not a smart self-experiment for most readers.
Decision rule (what to do instead this week)
If this issue made you worry about getting less return from training, do not jump to Humanin.
Do this instead:
keep training stable for 4 weeks
measure estimated VO2max or pace at a fixed heart rate
track recovery honestly
review why metformin is in the stack
if you are on long-term metformin, make sure B12 status is not being ignored
In other words:
Measure the proven lever before chasing the speculative peptide.
Hard disclaimer (please read)
Humanin and Humanin analogs are educational / research-watchlist territory, not self-optimization basics.
Do not self-source them.
Do not treat review-level excitement as evidence of routine clinical usefulness.
Do not assume purity, identity, sterility, or dose accuracy from gray-market peptide products.
And do not use this newsletter as a substitute for medical care – especially if you are dealing with diabetes, insulin resistance, neuropathy symptoms, or medication decisions.
QUICK POLL
Which part of this issue hit hardest?
QUOTE TO REMEMBER
💡 You are not just collecting health inputs. You are building a system.
Closing Note
The people who do best over time are usually not the ones with the most impressive-looking stack.
They are the ones who keep checking whether the stack is actually producing the result they wanted.
That is the bigger lesson in this issue.
Not just whether metformin and exercise interact in a messy way.
But whether you are building health by measurement and feedback – or by hope, reputation, and assumptions.
If you run the 4-week experiment, reply and send us your numbers.
And if this issue clarified something for you, forward it to one person who is training hard while taking metformin.
Want the "Pro" version of this newsletter? Deep dive + implementation upgrade + peptide dossier? Stay tuned. We're releasing it soon.
Until next time,
Live longer. Upgrade wisely.
Rolf & the HEALTH HACK team
PS: If someone sent you this, you can subscribe here: Vitality Signals
Disclaimers
Educational only. This newsletter is not medical advice.
Consult your clinician before changing medication, supplements, or training.
Do not delay care.
Do not self-source peptides.




